Observational Study on Financial Toxicity in Sarcoma Patients

This study is looking at the financial stress (financial toxicity) that patients experience when they have surgery for bone or soft tissue sarcomas (cancers of the bone or soft tissues). Researchers want to understand how much financial stress patients have and how it affects their quality of life. They will collect information from your electronic health records and ask you to complete questionnaires. This study is for adult orthopedic oncology patients who are seen before surgery for a primary malignant bone tumor or primary malignant soft tissue tumor. The study aims to understand the prevalence and severity of financial toxicity, identify risk factors, and see how different characteristics might worsen financial stress. The study plans to enroll 100 participants, but its current status is unclear.

Study design
This is an observational study that plans to enroll 100 adult participants. It is not testing a new treatment but rather collecting information.
What's involved
You would participate by having your electronic health records reviewed and completing questionnaires. This data collection will occur through study completion, which is an average of 1 year.
Compensation
Not stated in the trial record.
Follow-up
You will be followed through study completion, which is an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07215611

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

Recruiting
Not specifiedAll AgesObservational
M.D. Anderson Cancer Center
~100 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:data collection

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Questionnaires
Measured over Through study completion; an average of 1 year
Bone Sarcomas
Financial Toxicity
1 sites across 1 states
Texas1
  • Shalin S Patel, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified.
Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor.
  • QuestionnairesThrough study completion; an average of 1 year